Questions discussed in this category
CT changes are subsolid and ground glass nodules.
Is this managed as CTD-ILD with immunosuppressive +/- anti-fibrotic agents?
Patient is with past history of glomerulonephritis in remission after rituximab for the past 2 years. +MPO/P-ANCA
20552200272105519957175991469515731
Papers discussed in this category
The Lancet. Respiratory medicine, 2016-09
Respirology, 2013 Nov 29
Respir Res, 2022 Jun 21
J Infect Dis, 2020 Jun 11
Clin Chest Med, 2013 Apr 08
Arthritis & rheumatology (Hoboken, N.J.), 2015-05
International journal of rheumatic diseases, 2014-02
Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG, 2014-04-18
Clinical nuclear medicine, 2016-05
J Investig Med High Impact Case Rep, 2021 Jan-Dec
Clinical therapeutics, 2018 Feb
Current opinion in pulmonary medicine, 2023 Jun 30
Rheumatology (Oxford, England), 2023 Feb 01
N. Engl. J. Med., 2019 May 20
N Engl J Med, 2019 Sep 29
Rheumatology (Oxford),
Rheumatology (Oxford, England), 2023 Dec 01